Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$86.53
0.320.37%
At close: -
$86.53
0.000.00%
After Hours: Dec 20, 4:03 PM EDT
Comments
Loading...
Vaxcyte (NASDAQ:PCVX) Stock, Analyst Ratings, Price Targets, Forecasts
Vaxcyte Inc has a consensus price target of $127.22 based on the ratings of 11 analysts. The high is $163 issued by Mizuho on September 10, 2024. The low is $60 issued by SVB Leerink on December 16, 2022. The 3 most-recent analyst ratings were released by Goldman Sachs, Needham, and Mizuho on December 20, 2024, November 6, 2024, and September 10, 2024, respectively. With an average price target of $146 between Goldman Sachs, Needham, and Mizuho, there's an implied 68.73% upside for Vaxcyte Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
Needham
Mizuho
B of A Securities
Leerink Partners
1calculated from analyst ratings
Analyst Ratings for Vaxcyte
Data brought to you by Benzinga APIs
FAQ
What is the target price for Vaxcyte (PCVX) stock?
The latest price target for Vaxcyte (NASDAQ:PCVX) was reported by Goldman Sachs on December 20, 2024. The analyst firm set a price target for $135.00 expecting PCVX to rise to within 12 months (a possible 56.02% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vaxcyte (PCVX)?
The latest analyst rating for Vaxcyte (NASDAQ:PCVX) was provided by Goldman Sachs, and Vaxcyte initiated their buy rating.
When was the last upgrade for Vaxcyte (PCVX)?
There is no last upgrade for Vaxcyte
When was the last downgrade for Vaxcyte (PCVX)?
There is no last downgrade for Vaxcyte.
When is the next analyst rating going to be posted or updated for Vaxcyte (PCVX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxcyte, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxcyte was filed on December 20, 2024 so you should expect the next rating to be made available sometime around December 20, 2025.
Is the Analyst Rating Vaxcyte (PCVX) correct?
While ratings are subjective and will change, the latest Vaxcyte (PCVX) rating was a initiated with a price target of $0.00 to $135.00. The current price Vaxcyte (PCVX) is trading at is $86.53, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.